news06 April 2021Da Volterra Receives FDA Fast Track Designation for its Novel Microbiome Protector DAV132 • FDA Fast Track Designation has been granted to DAV132 for the prevention of Clostridioides difficile infection, a life-threatening…more
news15 March 2021Da Volterra attending BIO-Europe Spring® Digital on March 22-25, 2021The “must-attend” BIO-Europe event series has gone digital, and continues to grow, proving its importance and relevance to the life…more
news08 March 2021New review published in Drug Discovery Today highlights the crucial role of the intestinal microbiome in health and disease and the need for microbiome protectorsDa Volterra is pleased to present the latest publication of the team on the role of the gut microbiome and…more
news03 February 2021Da Volterra Receives first Authorizations from Regulatory Authorities in EU Countries to Initiate its Phase 3 Clinical Trial Evaluating the Microbiome Protector DAV132 in Patients with Hematologic Malignancies • World-first phase 3 study of a microbiome protector • Da Volterra becomes a pioneering late-stage clinical company…more
news18 December 2020Da Volterra’s CEO, Florence Séjourné, and CBO, Pierre-Alain Bandinelli, are attending Biotech Showcase™ Digital on January 11-15, 2021!Since its inception in 2009, Biotech Showcase has grown into one of the biopharma industry’s leading investor conferences, and is…more
news09 December 2020New data: confirmation of the negative impact of antibiotics on immuno-oncology patients’ survival in several types of cancersDa Volterra is presenting new data at the European Society for Medical Oncology (ESMO) Immuno-Oncology 2020 Virtual Meeting this week…more
news10 November 2020Da Volterra is presenting new data at Society for Immunotherapy of Cancer’s 2020 Virtual MeetingConfirmation of the negative impact of antibiotics on immuno-oncology patients’ survival Da Volterra is presenting new data at the Society…more
news19 October 2020Da Volterra is attending the Galien Week of Innovation on October 26-30, 2020The Galien Medstartup Partnering Week is a 5 days event dedicated to exhilirating online discussions and debates focused on global…more
news14 October 2020Da Volterra is attending BIO-Europe Digital on October 26-29, 2020!BIO-Europe is Europe’s largest partnering conference serving the global biotechnology industry. We look forward to virtually meeting with investors and…more
news17 September 2020Da Volterra presenting an e-poster entitled “A review of meta-analyses on the impact of antibiotics on the efficacy of immune checkpoint inhibitors and cancer patients’ survival” at the ESMO Virtual Congress.The e-poster highlights the need to develop innovative approaches to protect the intestinal microbiota of cancer patients treated with immune…more
